How We Stand Out

We give diligence its due. We apply rigorous quality control standards to ensure collected samples can be used immediately, not years later.
Data drives our decision making. Our deep sample analyses provide a more holistic view of a patient’s cancer and their immune system’s defensive response, enabling science that will help treat more patients and cancers.

Synergy is in our core. Our clinical trials and research studies are fully integrated within the BioTrust, which banks samples and reports testing results in a standardized way so comparisons across studies can further our understanding of immunotherapy’s promise and potential.
We power the research engine. Researchers can access our growing collection of 30,000+ tissue and blood samples to inform their research. In turn, they contribute data to our knowledge engine for others to access and build upon.

Meet Our Experts

Cheryl Selinsky, PhD
Vice President, Research Operations

Christopher Perry
Associate Director, Biospecimen Acquisition and Operations

Nikesh Kotecha, PhD
Vice President, Informatics

Nicholas Bayless, PhD
Senior Research Scientist

Lacey Kitch, PhD
Director, Informatics

Theresa LaVallee, PhD
Vice President, Translational Medicine and Regulatory Affairs